Entera Bio (ENTX) Short Interest Ratio & Short Volume $2.38 -0.16 (-6.30%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$2.36 -0.02 (-0.84%) As of 10/15/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entera Bio Short Interest DataEntera Bio (ENTX) has a short interest of 47,700 shares. This marks a 31.04% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 130,913 shares to cover all short positions.Current Short Interest47,700 sharesPrevious Short Interest36,400 sharesChange Vs. Previous Month+31.04%Dollar Volume Sold Short$87.29 thousandShort Interest Ratio0.4 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares45,660,000 sharesPercentage of Shares Shorted0.10%Today's Trading Volume247,324 sharesAverage Trading Volume130,913 sharesToday's Volume Vs. Average189% Short Selling Entera Bio? Sign up to receive the latest short interest report for Entera Bio and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENTX Short Interest Over TimeENTX Days to Cover Over TimeENTX Percentage of Float Shorted Over Time Entera Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202547,700 shares $87.29 thousand +31.0%N/A0.4 $1.83 8/31/202536,400 shares $70.25 thousand -2.2%0.1%0.3 $1.93 8/15/202537,200 shares $74.40 thousand -33.0%N/A0.3 $2.00 7/31/202555,500 shares $107.12 thousand +48.4%0.1%0.5 $1.93 7/15/202537,400 shares $70.31 thousand -32.4%N/A0.9 $1.88 6/30/202555,300 shares $105.07 thousand -22.9%0.1%1.4 $1.90 6/15/202571,700 shares $133.36 thousand -9.5%0.2%1.8 $1.86 5/31/202579,200 shares $145.33 thousand +57.5%0.2%1.9 $1.84 5/15/202550,300 shares $100.85 thousand -64.2%0.2%1.1 $2.01 4/30/2025140,500 shares $304.89 thousand +92.2%N/A2.7 $2.17 Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 4/15/202573,100 shares $132.31 thousand -2.3%0.2%1.3 $1.81 3/31/202574,800 shares $127.16 thousand -13.1%0.2%1.1 $1.70 3/15/202586,100 shares $161.87 thousand -13.7%0.3%0.8 $1.88 2/28/202599,800 shares $184.63 thousand -4.5%0.3%0.8 $1.85 2/15/2025104,500 shares $253.94 thousand +59.5%0.3%0.9 $2.43 1/31/202565,500 shares $143.45 thousand -31.6%N/A0.5 $2.19 1/15/202595,800 shares $218.42 thousand +102.5%N/A0.7 $2.28 12/31/202447,300 shares $100.28 thousand -23.1%N/A0.4 $2.12 12/15/202461,500 shares $132.84 thousand -2.4%N/A0.9 $2.16 11/30/202463,000 shares $103.32 thousand +19.8%N/A0.9 $1.64 11/15/202452,600 shares $91.00 thousand +19.0%N/A0.8 $1.73 10/31/202444,200 shares $80.00 thousand +9.4%N/A1.4 $1.81 10/15/202440,400 shares $73.12 thousand -14.4%N/A1.1 $1.81 9/30/202447,200 shares $89.68 thousand +38.4%N/A1.2 $1.90 9/15/202434,100 shares $67.86 thousand +27.7%N/A0.7 $1.99 8/31/202426,700 shares $44.59 thousand -4.0%N/A0.5 $1.67 8/15/202427,800 shares $44.48 thousand +11.7%N/A0.5 $1.60 7/31/202424,900 shares $40.09 thousand -51.0%N/A0.3 $1.61 7/15/202450,800 shares $95.00 thousand -29.4%N/A0.5 $1.87 6/30/202471,900 shares $132.30 thousand -7.2%N/A0.4 $1.84 6/15/202477,500 shares $160.43 thousand -15.2%N/A0.4 $2.07 5/31/202491,400 shares $205.65 thousand -28.0%N/A0.4 $2.25 5/15/2024127,000 shares $332.74 thousand +260.8%N/A0.5 $2.62 4/30/202435,200 shares $68.99 thousand -60.9%N/A0.1 $1.96 4/15/202489,900 shares $226.55 thousand +1.9%N/A0.4 $2.52 3/31/202488,200 shares $147.29 thousand +988.9%N/A0.5 $1.67 3/15/20248,100 shares $11.10 thousand +523.1%N/A0.1 $1.37 2/29/20241,300 shares $1.79 thousand -95.0%N/A0 $1.38 2/15/202426,100 shares $27.41 thousand +715.6%N/A0.3 $1.05 1/31/20243,200 shares $2.66 thousand -80.5%N/A0 $0.83 1/15/202416,400 shares $17.88 thousand -73.9%0.1%0.2 $1.09 12/31/202362,800 shares $37.68 thousand +5.7%0.3%1.2 $0.60 12/15/202359,400 shares $39.06 thousand -13.0%0.3%1.7 $0.66 11/30/202368,300 shares $47.92 thousand -3.1%0.3%2.1 $0.70 11/15/202370,500 shares $50.49 thousand +29.6%0.3%2.1 $0.72 10/31/202354,400 shares $37.30 thousand +8.8%0.3%1.3 $0.69 10/15/202350,000 shares $36.50 thousand -16.0%0.2%1.2 $0.73 9/30/202359,500 shares $43.14 thousand +18.3%0.3%1.5 $0.73 9/15/202350,300 shares $34.46 thousand +89.1%0.2%1.3 $0.69 8/31/202326,600 shares $17.82 thousand +24.9%0.1%0.8 $0.67 8/15/202321,300 shares $12.78 thousand -42.7%0.1%0.6 $0.60 7/31/202337,200 shares $29.39 thousand +268.3%0.2%1.3 $0.79 7/15/202310,100 shares $8.56 thousand -55.5%0.1%0.3 $0.85 6/30/202322,700 shares $19.15 thousand +291.4%0.1%0.7 $0.84 6/15/20235,800 shares $4.87 thousand -82.3%0.0%0.1 $0.84 5/31/202332,800 shares $26.01 thousand -12.8%0.2%0.5 $0.79 5/15/202337,600 shares $38.04 thousand -23.7%0.2%0.2 $1.01 4/30/202349,300 shares $37.96 thousand -54.5%0.2%0.2 $0.77 4/15/2023108,400 shares $92.63 thousand -52.5%0.5%0.5 $0.85 3/31/2023228,200 shares $264.71 thousand +22.8%1.0%1 $1.16 3/15/2023185,900 shares $187.76 thousand +114.4%0.8%0.8 $1.01 2/28/202386,700 shares $77.68 thousand +181.5%0.4%0.4 $0.90 2/15/202330,800 shares $29.06 thousand -3.5%0.1%0.5 $0.94 1/31/202331,900 shares $29.28 thousand -0.6%0.1%0.3 $0.92 1/15/202332,100 shares $26.64 thousand -47.5%N/A0.3 $0.83 12/30/202261,100 shares $44.60 thousand +8.5%N/A0.5 $0.73 12/15/202256,300 shares $35.29 thousand -8.5%N/A0.5 $0.63 11/30/202261,500 shares $41.75 thousand -43.4%N/A0.5 $0.68 11/15/2022108,700 shares $58.46 thousand -26.6%N/A0.9 $0.54 10/31/2022148,100 shares $115.90 thousand +119.7%N/A1.9 $0.78 10/15/202267,400 shares $56.62 thousand +160.2%N/A1 $0.84 9/30/202225,900 shares $26.94 thousand -54.8%N/A0.4 $1.04 9/15/202257,300 shares $76.21 thousand +38.7%N/A1.7 $1.33 8/31/202241,300 shares $55.76 thousand -5.9%N/A1.1 $1.35 8/15/202243,900 shares $77.70 thousand -48.5%N/A1.4 $1.77 7/31/202285,300 shares $165.48 thousand +9.1%N/A2.5 $1.94 7/15/202278,200 shares $109.48 thousand -11.4%N/A2.4 $1.40 6/30/202288,300 shares $117.44 thousand -30.3%N/A2.6 $1.33 6/15/2022126,700 shares $219.19 thousand -14.7%N/A3.4 $1.73 5/31/2022148,600 shares $319.49 thousand +4.2%N/A4.2 $2.15 5/15/2022142,600 shares $306.59 thousand -1.7%N/A3.9 $2.15 4/30/2022145,000 shares $355.25 thousand +10.1%N/A3.6 $2.45 4/15/2022131,700 shares $345.05 thousand -24.7%N/A2.5 $2.62 3/31/2022174,800 shares $501.68 thousand -13.1%N/A2.9 $2.87 3/15/2022201,200 shares $440.63 thousand -2.5%N/A1.9 $2.19 2/28/2022206,400 shares $439.63 thousand +12.7%N/A1.9 $2.13 2/15/2022183,200 shares $395.71 thousand -31.6%N/A1.6 $2.16 1/31/2022267,800 shares $613.26 thousand -11.0%N/A2.2 $2.29 1/15/2022300,800 shares $851.26 thousand +7.4%N/A0 $2.83 12/31/2021280,000 shares $789.60 thousand +9.3%N/A2.4 $2.82 12/15/2021256,300 shares $797.09 thousand +5.4%N/A2.9 $3.11 11/30/2021243,100 shares $811.95 thousand -16.8%N/A2.6 $3.34 11/15/2021292,200 shares $1.10 million -8.3%N/A2.8 $3.78 10/29/2021318,500 shares $1.36 million -3.7%N/A2.6 $4.26 10/15/2021330,800 shares $1.50 million -11.4%N/A2.1 $4.52 9/30/2021373,200 shares $1.76 million +21.3%N/A1.8 $4.71 9/15/2021307,600 shares $1.41 million -25.4%N/A0.7 $4.59 8/31/2021412,300 shares $2.01 million +119.5%N/A0.1 $4.88 8/13/2021187,800 shares $1.01 million +57.4%1.0%0.1 $5.40 7/30/2021119,300 shares $613.20 thousand -33.3%0.6%0 $5.14 7/15/2021178,800 shares $935.12 thousand -74.4%1.1%0.1 $5.23 6/30/2021697,100 shares $4.17 million +903.0%4.2%0.2 $5.98 6/15/202169,500 shares $259.24 thousand -9.4%0.4%0 $3.73 5/28/202176,700 shares $247.74 thousand -15.1%0.5%0 $3.23 5/14/202190,300 shares $263.68 thousand -57.1%N/A0 $2.92 4/30/2021210,400 shares $715.36 thousand +115.6%N/A0 $3.40 4/15/202197,600 shares $321.10 thousand +21.1%N/A0 $3.29 3/31/202180,600 shares $265.98 thousand -94.8%N/A0 $3.30 3/15/20211,540,000 shares $10.63 million +1,036.5%N/A0.2 $6.90 2/26/2021135,500 shares $239.84 thousand -13.4%N/A0.2 $1.77 2/12/2021156,500 shares $284.83 thousand +17.6%N/A0.2 $1.82 1/29/2021133,100 shares $185.01 thousand -8.8%N/A0.2 $1.39 1/15/2021145,900 shares $180.92 thousand +256.7%N/A0.3 $1.24 12/31/202040,900 shares $44.99 thousand -17.4%0.4%0.1 $1.10 12/15/202049,500 shares $52.97 thousand +56.7%0.5%0.1 $1.07 11/30/202031,600 shares $33.50 thousand -41.2%0.3%0.3 $1.06 11/15/202053,700 shares $56.12 thousand +42.1%0.5%0.6 $1.05 10/30/202037,800 shares $41.58 thousand +7.4%0.4%0.3 $1.10 ENTX Short Interest - Frequently Asked Questions What is Entera Bio's current short interest? Short interest is the volume of Entera Bio shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 47,700 shares of ENTX short. Learn More on Entera Bio's current short interest. Is Entera Bio's short interest increasing or decreasing? Entera Bio saw a increase in short interest in September. As of September 15th, there was short interest totaling 47,700 shares, an increase of 31.0% from the previous total of 36,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Entera Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Entera Bio: Altimmune, Inc. (28.42%), Aldeyra Therapeutics, Inc. (8.98%), Lyell Immunopharma, Inc. (1.89%), Rocket Pharmaceuticals, Inc. (13.80%), Capricor Therapeutics, Inc. (26.57%), Alector, Inc. (7.66%), Humacyte, Inc. (26.13%), Canopy Growth Corporation (6.97%), Mereo BioPharma Group plc - Sponsored ADR (6.94%), Neurogene Inc. (23.38%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Entera Bio stock? Short selling ENTX is an investing strategy that aims to generate trading profit from Entera Bio as its price is falling. ENTX shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Entera Bio? A short squeeze for Entera Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTX, which in turn drives the price of the stock up even further. How often is Entera Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTX, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies Altimmune Short Interest Data Aldeyra Therapeutics Short Interest Data Lyell Immunopharma Short Interest Data Rocket Pharmaceuticals Short Interest Data Capricor Therapeutics Short Interest Data Alector Short Interest Data Humacyte Short Interest Data Canopy Growth Short Interest Data Mereo BioPharma Group Short Interest Data Neurogene Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENTX) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
